Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of rilpivirine versus efavirenz with two NRTIs in antiretroviral-naive adults with HIV-1 infection
2007-002647-25Phase 3Completed
- Sponsor
- Tibotec
- Start
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Human immunodeficiency virus infection type 1 comparing Rilpivirine plus 2 NRTIs with Efavirenz plus 2 NRTIs (2 arms). Primary endpoint: Virologic response at Week 48. Started Sep 2007; status: completed.
02
Drugs
rilpivirineefavirenz
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on 2007-002647-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002647-25.